About Injective Labs
Injective Labs is a research and development company focused on creating Web3 infrastructure and finance solutions, and is a core contributor to Injective — a finance-focused, open, interoperable Layer 1 blockchain compatible with Cosmos IBC and Ethereum. The platform enables DeFi developers to build decentralized applications with zero gas fees, fast transactions, and pre-built modules. It serves Web3 developers, DeFi projects, and institutional partners building the next generation of decentralized financial infrastructure.
Company details
Funding
Total raised
$190M
Last stage
Series D
Investors
Founders
Eric Chen
Co-founded Injective Labs in 2018. Previously a researcher at Innovating Capital working on trading strategies and protocol research. Studied at New York University (BS in CS and Finance). Featured on Forbes 30 Under 30 Finance list.
Albert Chon
Co-founded Injective Labs in 2018 alongside Eric Chen. Stanford University alumnus. Featured on Forbes 30 Under 30 Finance list.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.